The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
Open accessAbstract
Recent evidence indicates that cyclin-dependent kinases (CDKs, cdks) may be inappropriately activated in several neurodegenerative conditions. Here, we report that cdk5 expression and activity are elevated after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a toxin that damages the nigrostriatal dopaminergic pathway. Supporting the pathogenic significance of the cdk5 alterations are the findings that the general cdk inhibitor, flavopiridol, or expression of dominant-negative cdk5, and to a lesser extent dominant-negative cdk2, attenuates the loss of dopaminergic neurons caused by MPTP. In addition, CDK inhibition strategies attenuate MPTP-induced hypolocomotion and markers of striatal function independent of striatal dopamine. We propose that cdk5 is a key regulator in the degeneration of dopaminergic neurons in Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Estimation of nuclear population from microtome sections
Abercrombie, M. (1946) · The Anatomical Record · doi:10.1002/ar.1090940210 · Cited by 4,363
Neurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., & Kulkarni, A. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11173 · Cited by 894
Dendritic release of dopamine in the substantia nigra
Cheramy, A., Leviel, V., & Glowinski, J. (1981) · Nature · doi:10.1038/289537a0 · Cited by 735
Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m002466200 · Cited by 723
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715
The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F., & Tsai, L. H. (1996) · Genes & Development · doi:10.1101/gad.10.7.816 · Cited by 598
Kitagawa, M., Higashi, H., Jung, H. K., Suzuki-Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01097.x · Cited by 589
Freeman, R. S., Estus, S., & Johnson, E. M. (1994) · Neuron · doi:10.1016/0896-6273(94)90276-3 · Cited by 573
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons
Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L.-H., Kwon, Y. T., Girault, J.-A., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 552
Pharmacological inhibitors of cyclin-dependent kinases
Knockaert, M., Greengard, P., & Meijer, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02071-0 · Cited by 537
Przedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
Self-citationDopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals
Bjo¨rklund, A., & Lindvall, O. (1975) · Brain Research · doi:10.1016/0006-8993(75)90849-5 · Cited by 483
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 467
The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity
Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J., & Tsai, L.-H. (1998) · Nature · doi:10.1038/26034 · Cited by 404
Zukerberg, L. R., Patrick, G. N., Nikolic, M., Humbert, S., Wu, C.-L., Lanier, L. M., Gertler, F. B., Vidal, M., Van Etten, R. A., & Tsai, L.-H. (2000) · Neuron · doi:10.1016/s0896-6273(00)81200-3 · Cited by 395
p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during Neurodevelopment
Ko, J., Humbert, S., Bronson, R. T., Takahashi, S., Kulkarni, A. B., Li, E., & Tsai, L.-H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06758.2001 · Cited by 385
Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25
Kusakawa, G.-I., Saito, T., Onuki, R., Ishiguro, K., Kishimoto, T., & Hisanaga, S.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m907757199 · Cited by 381
Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., & Abeliovich, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00084-9 · Cited by 381
Vila, M., Jackson-Lewis, V., Vukosavic, S., Djaldetti, R., Liberatore, G., Offen, D., Korsmeyer, S. J., & Przedborski, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633998 · Cited by 372
Self-citationAhlijanian, M. K., Barrezueta, N. X., Williams, R. D., Jakowski, A., Kowsz, K. P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. A., Burkhardt, J. E., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040577797 · Cited by 341
Deregulation of Cdk5 in a Mouse Model of ALS
Nguyen, M. D., Larivière, R. C., & Julien, J.-P. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 338
Paudel, H. K., Lew, J., Ali, Z., & Wang, J. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49492-1 · Cited by 285
Neurofilaments in Health and Disease
Julien, J.-P., & Mushynski, W. E. (1998) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60823-5 · Cited by 282
Cyclin-dependent kinases as a therapeutic target for stroke
Osuga, H., Osuga, S., Wang, F., Fetni, R., Hogan, M. J., Slack, R. S., Hakim, A. M., Ikeda, J.-E., & Park, D. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170144197 · Cited by 281
Self-citationCrocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., Callaghan, S. M., Slack, R. S., Melloni, E., Przedborski, S., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04081.2003 · Cited by 274
Self-citationPark, D. S., Levine, B., Ferrari, G., & Greene, L. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-08975.1997 · Cited by 265
Self-citationCyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents
Park, D. S., Morris, E. J., Padmanabhan, J., Shelanski, M. L., Geller, H. M., & Greene, L. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.457 · Cited by 263
Self-citationGong, X., Tang, X., Wiedmann, M., Wang, X., Peng, J., Zheng, D., Blair, L. A. C., Marshall, J., & Mao, Z. (2003) · Neuron · doi:10.1016/s0896-6273(03)00191-0 · Cited by 262
Giovanni, A., Keramaris, E., Morris, E. J., Hou, S. T., O'Hare, M., Dyson, N., Robertson, G. S., Slack, R. S., & Park, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11553 · Cited by 205
Self-citationEvidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms
Robertson, G., & Robertson, H. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-09-03326.1989 · Cited by 198
Bu, B., Li, J., Davies, P., & Vincent, I. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06515.2002 · Cited by 188
Doucet, J. ‐., Nakabeppu, Y., Bedard, P. J., Hope, B. T., Nestler, E. J., Jasmin, B. J., Chen, J. ‐., Ladarola, M. J., St‐Jean, M., Wigle, N., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01220.x · Cited by 186
A novel disruption of cortical development inp35?/? mice distinct fromreeler
Kwon, Y. T., & Tsai, L. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980615)395:4<510::aid-cne7>3.0.co;2-4 · Cited by 168
Nguyen, M. D., Boudreau, M., Kriz, J., Couillard-Després, S., Kaplan, D. R., & Julien, J.-P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02131.2003 · Cited by 161
Induction and Modulation of Cerebellar Granule Neuron Death by E2F-1
O'Hare, M. J., Hou, S., Morris, E. J., Cregan, S. P., Xu, Q., Slack, R. S., & Park, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001725200 · Cited by 155
Self-citationPhosphorylation of Pak1 by the p35/Cdk5 Kinase Affects Neuronal Morphology
Rashid, T., Banerjee, M., & Nikolić, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105599200 · Cited by 153
Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.
Brion, J., & Couck, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 136
Dopamine Neurons from Transgenic Mice with a Knockout of the p53 Gene Resist MPTP Neurotoxicity
Trimmer, P. A., Smith, T. S., Jung, A. B., & Bennett, J. P. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0031 · Cited by 136
Cdk5 phosphorylates p53 and regulates its activity
Zhang, J., Krishnamurthy, P., & Johnson, G. V. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00824.x · Cited by 121
Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease
Eberhardt, O., & Schulz, J. B. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00428-9 · Cited by 118
Wang, F., Corbett, D., Osuga, H., Osuga, S., Ikeda, J., Slack, R. S., Hogan, M. J., Hakim, A. M., & Park, D. S. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200202000-00005 · Cited by 110
Self-citationKim, K. S., Sack, J. S., Tokarski, J. S., Qian, L., Chao, S. T., Leith, L. W., Kelly, Y. F., Misra, R. N., Hunt, J. T., Kimball, S. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000231g · Cited by 104
c-Jun mediates axotomy-induced dopamine neuron death in vivo
Crocker, S. J., Lamba, W. R., Smith, P. D., Callaghan, S. M., Slack, R. S., Anisman, H., & Park, D. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231177098 · Cited by 92
Self-citationp35 nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease
Nakamura, S., Kawamoto, Y., Nakano, S., Akiguchi, I., & Kimura, J. (1997) · Acta Neuropathologica · doi:10.1007/s004010050687 · Cited by 82
The Cdk5‐p35 kinase associates with the Golgi apparatus and regulates membrane traffic
Paglini, M. G., Peris, L., Díez‐Guerra, J., Quiroga, S., & Cáceres, A. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve250 · Cited by 78
Induction of Cyclin B and H1 Kinase Activity in Apoptotic PC12 Cells
Gao, C., & Zelenka, P. S. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1271 · Cited by 63
Cdk5/p25nck5a interaction with synaptic proteins in bovine brain
Rosales, J. L., Nodwell, M. J., Johnston, R. N., & Lee, K. (2000) · Journal of Cellular Biochemistry · Cited by 59
El‐Khodor, B. F., Oo, T. F., Kholodilov, N. G., & Burke, R. E. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8047 · Cited by 59
Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.
Price, B. D., Hughes‐Davies, L., & Park, S. J. (1995) · PubMed · Cited by 57
Cellular Mechanisms of Striatum-Dependent Behavioral Plasticity and Drug Addiction
Fasano, S., & Brambilla, R. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362005 · Cited by 50
Neystat, M., Rzhetskaya, M., Oo, T. F., Kholodilov, N. G., Yarygina, O., Wilson, A., El‐Khodor, B. F., & Burke, R. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00376.x · Cited by 43
Expression and Activity of Cyclin‐Dependent Kinase 5/p35 in Adult Rat Peripheral Nervous System
Terada, M., Yasuda, H., Kogawa, S., Maeda, K., Haneda, M., Hidaka, H., Kashiwagi, A., & Kikkawa, R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062600.x · Cited by 33
Amphetamine Induces Hypermotility in MPTP-Lesioned Mice
Schröeder, U., Kreutz, M. R., Schroeder, H., & Sabel, B. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00291-2 · Cited by 10
Cited by
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Kim, R. H., Smith, P. D., Aleyasin, H., Hayley, S., Mount, M. P., Pownall, S., Wakeham, A., You-Ten, A. J., Kalia, S. K., Horne, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501282102 · Cited by 701
Self-citationUnderstanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Pharmacological inhibitors of glycogen synthase kinase 3
MEIJER, L., FLAJOLET, M., & GREENGARD, P. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.006 · Cited by 584
Roscovitine Targets, Protein Kinases and Pyridoxal Kinase
Bach, S., Knockaert, M., Reinhardt, J., Lozach, O., Schmitt, S., Baratte, B., Koken, M., Coburn, S. P., Tang, L., Jiang, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500806200 · Cited by 356
Metadata
- Authors
- Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., Anisman, H., & Park, D. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-10-31
- Volume
- 100
- Issue
- 23
- Pages
- 13650-13655
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2117743221
- Cited by
- 319
- References
- 58
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.